Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion
Crossref DOI link: https://doi.org/10.1007/s00223-016-0141-7
Published Online: 2016-04-20
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reyes, Carlen
Pottegård, Anton
Schwarz, Peter
Javaid, M. Kassim
Van Staa, Tjeerd P.
Cooper, Cyrus
Diez-Perez, Adolfo
Abrahamsen, Bo
Prieto-Alhambra, Daniel
Text and Data Mining valid from 2016-04-20